Become Affiliate
PepFlow app icon

PepFlow

Download

The Thymus Extract

Thymalin

A thymus-derived peptide mixture associated with immune-cell signaling, distinct from the zinc-dependent hormone thymulin.

Calm inflammation
TierC
EvidenceLimited
SafetyLimited Data
FDA statusNot Approved
Last reviewed October 25, 2026 43 citations How to read these labels

What is Thymalin?

Thymalin is a mixture of peptides extracted from thymus tissue. The thymus supports the development of T cells, a group of immune cells involved in recognizing infections and regulating immune responses.[6][1]

A tissue extract contains multiple components rather than one established amino-acid sequence. Its biological activity therefore depends on the preparation, not simply on a short peptide name or a nominal milligram amount.[6][40]

Thymalin differs from thymulin, a nine-amino-acid hormone whose activity requires zinc. Similar names do not make the extract, a purified hormone and other thymic peptides equivalent.[6][42]

What Thymalin is investigated for

Thymalin evidence is grouped by practical use case and intramuscular and topical route context. Each use case separates confidence, human evidence, animal or mechanistic support, and the practical takeaway.

Recovery during respiratory illness

Intramuscular

38%Preliminary

Possible adjunctive recovery benefits remain preliminary.[7][8]

Human evidence

Evidence suggests possible support for recovery alongside usual care, with limited clinical confidence.[7][8]

Animal / mechanistic evidence

Immune-cell experiments provide a possible inflammatory-signaling rationale, not proof of clinical recovery.[6]

Immune function during aging

Intramuscular

35%Preliminary

A lasting independent immune benefit remains uncertain.[1]

Human evidence

Human immune findings are preliminary and vary with the preparation and treatment context.[1]

Animal / mechanistic evidence

Cell and animal experiments examine thymic peptide effects on inflammatory and immune signaling.[6]

Infection susceptibility

Intramuscular

35%Preliminary

A reliable reduction in infection risk remains unestablished.[1]

Human evidence

A reliable reduction in infection susceptibility remains unestablished.[1]

Animal / mechanistic evidence

Immune signaling can be measured in cell models, but those measurements do not establish fewer infections in people.[6]

Longevity

Intramuscular

15%Insufficient

Longevity remains a research interest, with no established human lifespan benefit.[1]

Human evidence

Human lifespan extension has not been established for Thymalin.[1]

Animal / mechanistic evidence

Cell or animal immune findings cannot establish an increase in human lifespan.[6]

Evidence snapshot

38%

Human evidence

Preliminary

Human immune and recovery findings are preliminary and treatment-specific.[1][8]

32%

Animal / preclinical

Limited

Preclinical findings concern immune-cell activity and inflammatory signaling.[1][2][3][4][5][6]

30%

Mechanism support

Limited

Thymus-derived peptides may influence immune-cell activity and inflammatory cytokines, the chemical messages that coordinate an immune response.[6]

Forms & administration

Thymalin has a 10 mg freeze-dried vial for intramuscular injection, with product-specific reconstitution. Local ear formulations remain experimental and require separate preparation.[40][8][39][7]

IntramuscularTopical

Dosing & protocols

These ranges are general reference points, not personal dosing instructions.

Typical Range

Intramuscular amounts vary by preparation: 5–20 mg daily, including 10 mg per dose in adjunctive use.[7][8][43]

Frequency

Intramuscular administration is once daily.[7][8]

Timing Considerations

No general meal or bedtime anchor is specified.[7][8]

Cycle Length

Courses vary by preparation and purpose, generally 3–10 days.[7][8][43]

Safety profile

Hospital and historical reports use different thymus extracts and accompanying treatments. Their short courses and incomplete adverse-event reporting do not establish a common side-effect rate or repeated-course safety.[8][1]

Cautions

  • Extracts and local preparations are not interchangeable[40][39]

What we don't know

Long-term effects, drug interactions and safety in pregnancy require direct study of the same standardized extract.[8][1]

How it works

Thymus-derived peptides may influence immune-cell activity and inflammatory cytokines, the chemical messages that coordinate an immune response.[6]

Because Thymalin is a mixture, its activity depends on the preparation. The contribution of individual peptide components remains uncertain.[8][1]

Research gaps & open questions

What the current literature has not yet settled about Thymalin:

01

Controlled studies need to standardize the extract and compare recovery, infections and adverse effects with the same usual care, rather than relying only on immune-cell markers.[8][6]

02

Independent long-term trials need to separate Thymalin alone from other thymic or pineal peptides. The observational aging report cannot establish a causal increase in lifespan.[1]

03

Preparation comparisons need to establish whether historical extracts, current lyophilisates and local formulations contain equivalent active components and produce comparable exposure.[40][6][39]

Common questions

Is Thymalin the same as thymulin?

No. Thymalin is a thymus-derived mixture; thymulin is a defined nine-amino-acid, zinc-dependent hormone. Their preparations and schedules are different.[6][42]

Has Thymalin been shown to extend human lifespan?

Not proven. Human lifespan extension has not been established for Thymalin.[1]

History & discovery

Thymalin’s history centers on thymus-extract preparations and regional clinical use. Different extract formulations and combined treatments complicate comparisons across decades of reports.[3][1]

Early papers examined the extract in varied illness and recovery settings. Many abstracts provide limited treatment and adverse-event detail, leaving uncertainty about how the preparations compare.[3][5]

Later work included a long observational aging study and COVID-19 adjunct reports. Separate and combination groups must be distinguished; neither a longevity claim nor a general immune treatment follows from these designs.[1][8]

Published research43 citations

Thymalin research focuses on immune regulation, infection susceptibility and recovery. Clinical findings are preliminary and preparation-specific; a general immune-restoration or longevity benefit remains unestablished.[1][8][6][5][13][20][15][27][30][32]

Show citationsHide citations
[1]Peptides of pineal gland and thymus prolong human lifeNeuro Endocrinol Lett, 2003 Jun-Aug. human clinical.[2][Use of thymic peptide thymalin in the complex treatment of therapy-resistant schizophrenia]Zh Nevropatol Psikhiatr Im S S Korsakova, 1990. human clinical.[3][Use of thymalin in trauma patients]Vestn Khir Im I I Grek, 1984 Feb. human clinical.[4][The effect of thymalin on lipid metabolism and the clinical course of ischemic heart disease]Lik Sprava, 1992 Sep. human clinical.[5][Effect of thymalin on immunologic reactivity of patients with non-specific lung diseases]Ter Arkh, 1989. human clinical.[6]Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell LineInt J Mol Sci, 2022 Mar 25. in vitro.[7]Results and prospects of using activator of hematopoietic stem cell differentiation in complex therapy for patients with COVID-19Stem Cell Reviews and Reports, 2021. human clinical.[8]Peptide drug Thymalin regulates immune status in severe COVID-19 older patientsAdvances in Gerontology, 2021. human clinical.[9]Use of Thymalin to correct immune-status deviations in COVID-19: rationale and clinical caseVrach, 2020. human clinical.[10][Effect of thymalin on the status of immunogenesis and hemostasis in patients with ischemic heart disease].Ter Arkh, 1986. human clinical.[11][Experimental and clinical study of a new immunoregulator preparation thymalin].Voen Med Zh, 1982 May. human clinical.[12][Effects of thymalin on blood coagulation and contents of proinflammatory and anti-inflammatory cytokines in patients with burns].Vestn Khir Im I I Grek, 2000. human clinical.[13][Thymalin in the combined treatment of parkinsonism patients].Lik Sprava, 1999 Jan-Feb. human clinical.[14][Thymalin in the treatment of patients with erysipelas].Klin Med (Mosk), 1987 Jul. human clinical.[15]Application of thymic factor "Thymalin" in complex treatment of endometrial cancer patients.Eur J Gynaecol Oncol, 1990. human clinical.[16][Thymalin in the combined treatment of patients with chronic lympholeukemia].Vrach Delo, 1989 Mar. human clinical.[17][The cytomorphological characteristics of hemopoiesis and of the organs of immunogenesis in exposure to thymus and bone marrow peptides during hematopoietic depression].Arkh Patol, 1989. animal.[18][The application efficacy of immunomodulators in complex of treatment of an acute necrotic pancreatitis].Klin Khir, 2004 Sep. human clinical.[19][Morphological compound and indicators of the blood clotting system in severe COVID-19 patients of middle aged and elderly during treatment of Tocilizumab and Thymalin.].Adv Gerontol, 2022. human clinical.[20][The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis]Vrach Delo, 1989 Oct. human clinical.[21][Effectiveness of administration of thymalin in the complex treatment of pulmonary tuberculosis].Probl Tuberk, 1990. human clinical.[22][Clinico-immunologic changes in patients with cervical cancer after treatment with thymalin].Vopr Onkol, 1984. human clinical.[23][The effect of thymalin on biochemical and immunological indices of lymphocyte differentiation and functional activity].Vopr Med Khim, 1990. human clinical.[24]Contemporary Views on the Nature and Clinical Application of Thymus Preparations.Russ J Immunol, 1997 Dec. review.[25]Experimental and clinical study of the thymus polypeptide factor thymalin.Hum Physiol, 1984. human clinical.[26][Thymic polypeptide factor--thymalin in experiments and in clinical use].Fiziol Cheloveka, 1984. human clinical.[27][Thymalin in the treatment of herpetic stomatitis in children].Stomatologiia (Mosk), 1994. human clinical.[28]The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19.Int J Mol Sci, 2023 Aug. in vitro.[29]Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells.Bull Exp Biol Med, 2020 Nov. in vitro.[30]Expression features of T-lymphocytes, B-lymphocytes and macrophages in the post-traumatic regenerate of the mandible rats under conditions of filling a bone defect with hydroxyapatite-containing osteotropic material and thymalin injecting the surrounding soft tissues.Pol Merkur Lekarski, 2024. animal.[31]Reparative osteogenesis in mandible in cases of filling a bone defect with hydroxyapatite-containing osteotropic material and injecting the surrounding soft tissues with thymalin: experimental and morphological study.Wiad Lek, 2024. animal.[32]Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo.Bull Exp Biol Med, 2018 May. animal.[33]Chrono- and Immunocorrection of Inflammatory Disorders of Internal Reproductive Organs in Women of Reproductive Age.Bull Exp Biol Med, 2015 May. human clinical.[34][Comparative study of immunomodulatory activity of peptides, tinrostim and thymalin].Antibiot Khimioter, 2013. animal.[35][POLYPEPTIDES INFLUENCE ON TISSUE CELL CULTURES REGENERATION OF VARIOUS AGE RATS].Adv Gerontol, 2015. in vitro.[36][Possibilities of immunomodulation in patients with chronic bronchitis during physiotherapeutic impacts on the thymic area].Vopr Kurortol Fizioter Lech Fiz Kult, 2004. human clinical.[37]Peptide Regulation of Ageing: From Experiment to Practice.Current Aging Science, 2026. review.[38][Age features of bioregulatory therapy of dental diseases.].Advances in gerontology = Uspekhi gerontologii, 2020. review.[39][TREATMENT OF SECRETORY OTITIS MEDIA IN CHILDREN, DEPENDING ON THE STAGE OF THE PROCESS AND ON THE BACKGROUND OF THE PATHOLOGICAL CONDITIONS].Georgian medical news, 2019 Nov. human clinical.[40]Thymalin 10 mg intramuscular lyophilisate registry entryMinistry of Health of Uzbekistan medicines registry. regulatory.[41]Drugs@FDA brand/generic name search for ThymalinU.S. Food and Drug Administration, Drugs@FDA via OpenFDA. database query.[42]Thymulin and the neuroendocrine systemPeptides, 2004 Jan. review.[43]Thymalin product information and directions for useSamson-Med, 2022. product directions.

Keep It Organized

Bring consistency to your well-being routine.

Use PepFlow to record your Thymalin protocol, set reminders for your own schedule, and review your history.

Download on the App StoreGet it on Google Play
PepFlow calendar and scheduled protocols
iPhone showing PepFlow schedule tracking